Understanding how closely related coronaviruses circulate seasonally could impact the timing of vaccination against SARS-CoV-2.
A*STAR researchers have identified specific sites in the surface protein of influenza viruses that allow the pathogen to adapt to different host organisms.
The host immune system has a limited impact on the evolution of the influenza virus, A*STAR researchers find.
Infiltrating self-defense cells provoke kidney failure in a chronic autoimmune disease
A biosensor capable of sensitively detecting influenza viruses has potential for improving clinical diagnosis of Influenza A
A more efficient production process for influenza vaccines could help to cope with future pandemics
A decade after the opening of Biopolis, Singapore’s premier biomedical sciences research hub, A*STAR’s multifaceted activities are spurring discovery and innovation with a global reach
A*STAR’s new vaccine, based on a virus-like particle technology created by Cytos Biotechnology AG, could strengthen Singapore’s ability to tackle influenza pandemics
A computational algorithm for tracking influenza viral ancestry outperforms even human experts
A silicon-based microfluidic chip that distinguishes different viral strains shows potential for the quick on-site diagnosis of infectious diseases
A strain of H1N1 influenza virus that rapidly develops resistance to the antiviral drug oseltamivir has emerged